lactoferrin and Common-Cold

lactoferrin has been researched along with Common-Cold* in 7 studies

Reviews

2 review(s) available for lactoferrin and Common-Cold

ArticleYear
Lactoferrin for prevention of common viral infections.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:11

    Although lactoferrin has many biological functions, the host-protective effects against pathogenic microorganisms including bacteria, fungi, and viruses are regarded as one of the most important. Here, we review research on the protective role of lactoferrin administration against common viral infections. Many studies have shown the in vitro antiviral activity of lactoferrin against viral pathogens that cause common infections such as the common cold, influenza, gastroenteritis, summer cold, and herpes, where lactoferrin inhibits mainly viral attachment to the target cells. Recently, studies indicating the in vivo protective effects of lactoferrin by oral administration against common viral infections have been increasing. For instance, norovirus is an extremely important emerging human pathogen that causes a majority of gastroenteritis outbreaks worldwide that may be a target candidate for lactoferrin. Lactoferrin consumption reduced the incidence of noroviral gastroenteritis in children and a similar effect was observed in a wide range of ages in a preliminary survey. A recent in vitro study reported that lactoferrin inhibits both cellular attachment of the murine norovirus, a virus closely-related to the human norovirus, and viral replication in the cells by inducing antiviral cytokines interferon (IFN)-α/β. Lactoferrin administration also enhances NK cell activity and Th1 cytokine responses, which lead to protection against viral infections. In conclusion, lactoferrin consumption may protect the host from viral infections through inhibiting the attachment of a virus to the cells, replication of the virus in the cells, and enhancement of systemic immune functions.

    Topics: Anti-Infective Agents; Caliciviridae Infections; Common Cold; Gastroenteritis; Herpes Simplex; Humans; Influenza, Human; Lactoferrin; Norovirus; Rotavirus Infections; Seasons

2014
Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations.
    Alternative medicine review : a journal of clinical therapeutic, 2007, Volume: 12, Issue:1

    The common cold is the leading cause of doctor visits in the United States and annually results in 189 million lost school days. In the course of one year the U.S. population contracts approximately 1 billion colds. Influenza infection is still a leading cause of morbidity and mortality, accounting for 20-25 million doctor visits and 36,000 deaths per year in the United States. Conventional therapies for colds and flu focus primarily on temporary symptom relief and include over-the-counter antipyretics, anti-inflammatories, and decongestants. Treatment for influenza also includes prescription antiviral agents and vaccines for prevention. This article reviews the common cold and influenza viruses, presents the conventional treatment options, and highlights select botanicals (Echinacea spp., Sambucus nigra, larch arabinogalactan, Astragalus membranaceous, Baptisia tinctoria, Allium sativa, Panax quinquefolium, Eleutherococcus senticosus, Andrographis paniculata, olive leaf extract, and Isatis tinctoria) and nutritional considerations (vitamins A and C, zinc, high lactoferrin whey protein, N-acetylcysteine, and DHEA) that may help in the prevention and treatment of these conditions.

    Topics: Acetylcysteine; Antiviral Agents; Common Cold; Dehydroepiandrosterone; Humans; Influenza Vaccines; Influenza, Human; Lactoferrin; Nonprescription Drugs; Phytotherapy; Zinc

2007

Trials

2 trial(s) available for lactoferrin and Common-Cold

ArticleYear
Effects of lactoferrin on infectious diseases in Japanese summer: A randomized, double-blinded, placebo-controlled trial.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:4

    To investigate the effects of lactoferrin (LF) on infectious diseases in Japanese summer.. An intake of placebo, 200 mg, or 600 mg of LF were administered to healthy adults in Kyushu University of Health and Welfare for 12 weeks in a randomized, double-blinded, placebo-controlled parallel-group comparative trial. The primary endpoints were the prevalence and duration of infectious diseases and changes in immune parameters.. Three hundred and ten subjects were randomized (placebo, n = 104; 200 mg, n = 103; 600 mg, n = 103). Twenty subjects were lost to the follow-up, leaving 290 for a full analysis set (n = 99; n = 95; n = 96). The duration (day) of total infectious diseases was shorter in the 200 mg group (2.0, p = 0.045) and 600 mg group (2.0, p = 0.010) than in the placebo group (3.0). The duration of summer colds was shorter in the 600 mg group (2.0, p = 0.036) than in the placebo group (3.0). No significant differences were observed in the prevalence of infectious diseases or changes in immune parameters. In exploratory investigations, changes in the neutrophil phagocytic capacity, cortisol concentrations, and T score of "Vigor/Activity" in the Profile of Mood States 2 were greater in the 600 mg group than in the placebo group, when analysis was done on the lower half groups at the baseline. Adverse events were similar in each group and none had a causal relationship with the intake of the test foods.. In summer, the intake of LF attenuates infectious diseases, including summer colds.

    Topics: Adult; Aged; Anti-Infective Agents; Common Cold; Communicable Diseases; Double-Blind Method; Female; Humans; Japan; Lactoferrin; Male; Middle Aged; Respiratory Tract Infections; Seasons; Treatment Outcome; Young Adult

2021
The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: a double blind randomized study.
    Complementary therapies in medicine, 2013, Volume: 21, Issue:3

    The aim of the study was to determine if a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) combination was effective in reducing the number of colds and in turn improving symptom recovery in a cohort of males and females that reported frequently contracting a cold.. A double blind randomized placebo-controlled clinical trial.. One-hundred and twenty-six participants matched by age, BMI, dietary and physical parameters with self-reported frequent upper respiratory tract symptoms and infections were randomly assigned to receive 600 mg of Lf/IgF or a placebo daily for 90 days.. A total of 90 participants (47 receiving the active and 43 placebo) completed the 90 day trial and 15 completed 45 days participation (6 in the active and 9 in the placebo group). The total number of colds recorded over the study period was 48 for the treatment group versus 112 for the placebo group (p < 0.001). The significant trend was retained when the data was corrected for medications returned (p < 0.001) and for guessing treatment allocations (p < 0.001). Non-parametric analysis demonstrated that the total number of cold-associated symptoms reported by participants that received Lf/IgF was significantly less than those in the placebo group (p < 0.05). Also, total days sick with a cold and cold severity were reduced over the clinical trial period for Lf/IgF over placebo, but the trend was not significant.. These findings demonstrate that the Lf/IgF combination significantly decreased the incidence of colds and the cumulative number of cold-related symptoms over placebo. This therapeutic combination may be indicated for the prevention of colds and its most common symptoms in the general population when administered as a preventative supplement.

    Topics: Adolescent; Adult; Animals; Cattle; Common Cold; Double-Blind Method; Female; Humans; Immunoglobulin G; Incidence; Lactoferrin; Male; Middle Aged; Milk Proteins; Whey Proteins; Young Adult

2013

Other Studies

3 other study(ies) available for lactoferrin and Common-Cold

ArticleYear
Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired bacterial sinusitis.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:8

    To distinguish sinusitis from uncomplicated "colds," we examined lactoferrin and eosinophilic cationic protein (ECP) in nasal secretions. Lactoferrin titers were >/=1:400 in 4% of persons with uncomplicated colds and controls but in 79% of persons with sinusitis or purulent sputa. ECP levels were >200 ng/ml in 61% of persons with colds and >3,000 ng/ml in 62% of persons with sinusitis. Nasal lactoferrin helps distinguish sinusitis from colds.

    Topics: Bacterial Infections; Blood Proteins; Common Cold; Community-Acquired Infections; Eosinophil Granule Proteins; Humans; Lactoferrin; Mucus; Nasal Mucosa; Rhinovirus; Ribonucleases; Sinusitis

2000
Analysis of nasal secretions during experimental rhinovirus upper respiratory infections.
    The Journal of allergy and clinical immunology, 1993, Volume: 92, Issue:5

    To determine the underlying mechanisms for rhinovirus-induced nasal secretions, nasal lavage fluids were analyzed during experimental rhinovirus infections.. Twenty patients with allergic rhinitis and 18 nonallergic control subjects were inoculated with rhinovirus type 39. Nasal lavage was performed before and on days 2 through 7 after viral inoculation, and the lavage fluids were assayed for proteins and mast cell mediators.. The secretion of total protein and both plasma proteins (albumin and IgG) and glandular proteins (lactoferrin, lysozyme, and secretory IgA) increased after rhinovirus inoculation. Analysis of the specific protein constituents revealed that nasal secretions during the initial response to the rhinovirus infection were predominantly due to increased vascular permeability. Allergic subjects tended to have fewer symptoms and more vascular permeability than control subjects, and increased histamine secretion after rhinovirus inoculation was more frequently seen in the allergy group.. Nasal secretions found early in the course of a viral upper respiratory infection are due to increased vascular permeability, whereas glandular secretions predominate later in the infection.

    Topics: Adolescent; Adult; Common Cold; Female; Histamine; Humans; Immunoglobulin A, Secretory; Immunoglobulin G; Lactoferrin; Male; Mucus; Muramidase; Nasal Mucosa; Respiratory Tract Infections; Rhinovirus; Serum Albumin

1993
Association of lactoferrin with other proteins, as demonstrated by changes in electrophoretic mobility.
    Biochimica et biophysica acta, 1971, Dec-28, Volume: 251, Issue:3

    Lactoferrin in a number of human body fluids was found to possess different electrophoretic mobilities, while being immunologically identical. The isolated protein migrated slower than any of the naturally occurring forms. This phenomenon was found to be due to the property of human lactoferrin to interact strongly with acidic macromolecules, forming complexes with a faster migration than the single protein. Beside electrostatic interactions also other forces seem to be involved in the complex formation.

    Topics: Apoproteins; Body Fluids; Common Cold; Female; Humans; Immunoelectrophoresis; Lactoferrin; Male; Milk, Human; Protein Binding; Protein Isoforms; Saliva; Semen; Static Electricity

1971